Parallel exports: The French Competition Authority suggests amendments in order to limit the restrictions on parallel trade of medicinal products between EU Member States, while preserving the public health objective of the decree (Supply of medicinal products for human use)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Concordant Aut. opinion of 20 July 2012 on a draft decree on the supply of medicinal products for human use After veterinary medicinal products, which the Authority addressed in an opinion commented on in the previous column (this review Concurrences No. 3-2012, p. 99), the Authority turned its attention to medicines for human use following a referral for an opinion from

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.